Publication:
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy

dc.contributor.authorTesfaye, Amene
dc.contributor.authorRodríguez-Nogales, Alba
dc.contributor.authorBenedé, Sara
dc.contributor.authorFernández, Tahía D
dc.contributor.authorParis, Juan L.
dc.contributor.authorRodriguez, Maria J.
dc.contributor.authorJiménez-Sánchez, Isabel M.
dc.contributor.authorBogas, Gador
dc.contributor.authorMayorga, Cristobalina
dc.contributor.authorTorres, María J.
dc.contributor.authorMontañez, María I.
dc.contributor.authoraffiliation[Tesfaye,A; Rodríguez-Nogales,A; Paris,JL; Rodriguez,MJ; Jiménez-Sánchez,IM; Mayorga,C; Torres,MJ; Montañez,MI] Andalusian Centre for Nanomedicine and Biotechnology-BIONAND, Málaga, Spain. [Tesfaye,A; Rodríguez-Nogales,A; Fernández,TD; Paris,JL; Rodriguez,MJ; Jiménez-Sánchez,IM; Bogas,G; Mayorga,C; Torres,MJ; Montañez,MI] Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain. [Benedé,S] Instituto de Investigación en Ciencias de la Alimentación (CIAL, CSIC-UAM), Madrid, Spain. [Fernández,TD] Departamento de Biología Celular Genética y Fisiología. Facultad de Ciencias, Universidad de Málaga, Málaga, Spain, [Bogas,G; Mayorga,C;Torres,MJ] Allergy Unit, Hospital Regional Universitario de Málaga, Málaga, Spain. [Torres,MJ] Departamento de Medicina, Facultad de Medicina, Universidad de Málaga, Málaga, Spain.
dc.contributor.funderEuropean Union's H2020 research and innovation programme under the Marie Skłodowska-Curie, Grant/Award Number: 713721 Andalusian Regional Ministry Health Grant/Award Number: RC-0004-2021, PI-0699-2011 and PI-0179-2014 Institute of Health "Carlos III" Grant/Award Number PI12/02529, PI15/01206, PI18/00095, CP15/00103, PI17/01237, PI20/01734, PI20/01447, ARADYAL RD16/0006/0001 and Euronanomed Program AC19/00082
dc.date.accessioned2021-07-06T10:05:44Z
dc.date.available2021-07-06T10:05:44Z
dc.date.issued2021-03-30
dc.description.abstractBackground: Amoxicillin (AX) is nowadays the β-lactam that more frequently induces immediate allergic reactions. Nevertheless, diagnosis of AX allergy is occasionally challenging due to risky in vivo tests and non-optimal sensitivity of in vitro tests. AX requires protein haptenation to form multivalent conjugates with increased size to be immunogenic. Knowing adduct structural features for promoting effector cell activation would help to improve in vitro tests. We aimed to identify the optimal structural requirement in specific cellular degranulation to AX using well-precised nanoarchitectures of different lengths. Method: We constructed eight Bidendron Antigens (BiAns) based on polyethylene glycol (PEG) linkers of different lengths (600–12,000 Da), end-coupled with polyamidoamine dendrons that were terminally multi-functionalized with amoxicilloyl (AXO). In vitro IgE recognition was studied by competitive radioallergosorbent test (RAST) and antibody–nanoarchitecture complexes by transmission electron microscopy (TEM). Their allergenic activity was evaluated using bone marrow-derived mast cells (MCs) passively sensitized with mouse monoclonal IgE against AX and humanized RBL-2H3 cells sensitized with polyclonal antibodies from sera of AX-allergic patients. Results: All BiAns were recognized by AX-sIgE. Dose-dependent activation responses were observed in both cellular assays, only with longer structures, containing spacers in the range of PEG 6000–12,000 Da. Consistently, greater proportion of immunocomplexes and number of antibodies per complex for longer BiAns were visualized by TEM. Conclusions: BiAns are valuable platforms to study the mechanism of effector cell activation. These nanomolecular tools have demonstrated the importance of the adduct size to promote effector cell activation in AX allergy, which will impact for improving in vitro diagnostics.es_ES
dc.description.versionYeses_ES
dc.identifier.citationTesfaye A, Rodríguez-Nogales A, Benedé S, Fernández TD, Paris JL, Rodriguez MJ, et al. Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy. Allergy. 2021;00:1-11.es_ES
dc.identifier.doi10.1111/all.14834es_ES
dc.identifier.essn1398-9995
dc.identifier.issn0105-4538
dc.identifier.pmid33784407es_ES
dc.identifier.urihttp://hdl.handle.net/10668/3403
dc.journal.titleAllergy
dc.language.isoen
dc.page.number11 p.
dc.publisherJohn Wiley & Sons, Inces_ES
dc.relation.publisherversionhttps://onlinelibrary.wiley.com/doi/10.1111/all.14834es_ES
dc.rights.accessRightsopen access
dc.subjectIgE cross-linkinges_ES
dc.subjectamoxicillines_ES
dc.subjectdrug allergyes_ES
dc.subjectimmunocomplexes_ES
dc.subjectnanostructurees_ES
dc.subjectamoxicilinaes_ES
dc.subjecthipersensibilidad a las drogases_ES
dc.subjectnanoestructurases_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactams::Penicillins::Penicillin G::Ampicillin::Amoxicillines_ES
dc.subject.meshMedical Subject Headings::Technology and Food and Beverages::Technology, Industry, and Agriculture::Manufactured Materials::Nanostructureses_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Pharmaceutical Preparations::Drug Combinationses_ES
dc.subject.meshMedical Subject Headings::Diseases::Congenital, Hereditary, and Neonatal Diseases and Abnormalities::Genetic Diseases, Inborn::Metabolism, Inborn Errors::Porphyrias::Porphyrias, Hepatic::Porphyria, Variegatees_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactamses_ES
dc.titleNanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergyes_ES
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Tesfaye_NanoarchitecturesForEfficient.pdf
Size:
1.72 MB
Format:
Adobe Portable Document Format
Description: